![Ronald E. Cape](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald E. Cape
Geen lopende functies
Profiel
Ronald E.
Cape served as Chairman at Caprion Pharmaceuticals, Cetus Corp., and BYTC Corp.
He also served as Director at CASI Pharmaceuticals, Inc. and Neurobiological Technologies, Inc. Additionally, he was a Director at Gelesis, Inc., San Francisco Opera Association, and Follica, Inc. He also served as an Advisor at EARLYBIRD LLC.
Dr. Cape earned an MBA from Harvard University in 1955, a doctorate from McGill University in 1967, and an undergraduate degree from Princeton University in 1953.
Eerdere bekende functies van Ronald E. Cape
| Bedrijven | Functie | Einde |
|---|---|---|
BYTC Corp.
 BYTC Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Voorzitter | 30-01-2009 |
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for treating cancer and inflammatory diseases | Directeur/Bestuurslid | 05-06-2008 |
| NEUROBIOLOGICAL TECHNOLOGIES, INC. | Directeur/Bestuurslid | 31-12-2007 |
Caprion Pharmaceuticals, Inc.
 Caprion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovered and developed pharmaceutical products | Voorzitter | 16-03-2007 |
San Francisco Opera Association
 San Francisco Opera Association Movies/EntertainmentConsumer Services Owns and operates an opera theater | Directeur/Bestuurslid | - |
Opleiding van Ronald E. Cape
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
86
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for treating cancer and inflammatory diseases | Health Technology |
Neurobiological Technologies, Inc.
 Neurobiological Technologies, Inc. BiotechnologyHealth Technology Manufactures biological products | Health Technology |
Caprion Pharmaceuticals, Inc.
Caprion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovered and developed pharmaceutical products | Health Technology |
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops novel category of therapies for GI-related chronic diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cetus Corp.
 Cetus Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Francisco Opera Association
San Francisco Opera Association Movies/EntertainmentConsumer Services Owns and operates an opera theater | Consumer Services |
EARLYBIRD LLC
 EARLYBIRD LLC Investment ManagersFinance Earlybird seeks to invest in companies led by outstanding people who are creating major new markets. Most investments are made in the early-stages or during a phase of expansion while the company is privately held. The firm seeks a team with an entrepreneurial vision and skill-set with highly personal commitments to the success of the venture. They invest in companies that demonstrate vision and creativity with large, untapped market opportunities, and seek entrepreneurs with a passion for their ideas and the determination, commitment and skills needed to transform their vision into a successful business. The target investment’s market must be sufficiently expansive, with growth to enable significant annual sales in a few years. After a sufficient developmental period, they expect the company’s products and services to maintain growth potential and also generate a high level of profitability. Products or services should have a clear and sustainable competitive advantage based on product features protected by strong intellectual property and other barriers to entry while posting a moderate technology risk. Earlybird’s investment focus is software/information technology, communications, healthcare and convergent technologies. | Finance |
BYTC Corp.
BYTC Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Follica, Inc.
 Follica, Inc. Other Consumer ServicesConsumer Services Develops therapies for hair follicle disorders | Consumer Services |
